Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP21A2 mutations in women with polycystic ovary syndrome (PCOS).

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme - 1 May 2013

Settas N, Dracopoulou-Vabouli M, Dastamani A, Katsikis I, Chrousos G, Panidis D, Dacou-Voutetakis C

Abstract excerpt

The question of the contribution of CYP21A2 heterozygosity to the development of polycystic ovary syndrome (PCOS) has repeatedly been raised in the literature. The available data, however, do not offer a satisfactory answer. The discrepancy must be attributed, primarily, to the small number of subjects in the various studies, the type of selected phenotype, and the number of searched mutations. The aim of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgens
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Heterozygote

Share to Homozygote

Share to Polycystic Ovary Syndrome

Share to Steroid 21-Hydroxylase

Share to Young Adult

Source

Identifiers

PMID: 23386413
DOI: 10.1055/s-0033-1333727

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

CYP21A2 mutations in women with polycystic ovary syndrome (PCOS).PMID 23386413Read ↗

Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia.Semantic proximity Read ↗

Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency.Semantic proximity Read ↗

Impact of CYP19A1 genetic variations on polycystic ovary syndrome: findings from a case-control study.Semantic proximity Read ↗

The role of heterozygosity for CYP21 in the polycystic ovary syndrome.Semantic proximity Read ↗

Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess.Semantic proximity Read ↗

Molecular defects of the CYP21 gene in Spanish girls with isolated precocious pubarche.Semantic proximity Read ↗

Premature pubarche in Mediterranean girls: high prevalence of heterozygous CYP21 mutation carriers.Semantic proximity Read ↗

Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status.Semantic proximity Read ↗

The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.Semantic proximity Read ↗

Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls.Semantic proximity Read ↗

Lack of association between CYP21 V281L variant and polycystic ovary syndrome in Italian women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.